Market Cap : 297.96 M | Enterprise Value : 270.68 M | P/E (TTM) : 11.71 | P/B : 5.91 |
---|
NAS:CODX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:CODX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Co-Diagnostics's Enterprise Value is $270.68 Mil. Co-Diagnostics's EBIT for the trailing twelve months (TTM) ended in Sep. 2020 was $25.02 Mil. Therefore, Co-Diagnostics's EV-to-EBIT for today is 10.82.
During the past 5 years, the highest EV-to-EBIT of Co-Diagnostics was 70.00. The lowest was -68.90. And the median was -2.60.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Co-Diagnostics's Enterprise Value for the quarter that ended in Sep. 2020 was $374.96 Mil. Co-Diagnostics's EBIT for the trailing twelve months (TTM) ended in Sep. 2020 was $25.02 Mil. Co-Diagnostics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2020 was 6.67%.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* The bar in red indicates where Co-Diagnostics's EV-to-EBIT falls into.
Co-Diagnostics's EV-to-EBIT for today is calculated as:
EV-to-EBIT | = | Enterprise Value (Today) | / | EBIT (TTM) |
= | 270.677 | / | 25.022 | |
= | 10.82 |
Co-Diagnostics's current Enterprise Value is $270.68 Mil.
Co-Diagnostics's EBIT for the trailing twelve months (TTM) ended in Sep. 2020 was -1.735 (Dec. 2019 ) + -1.065 (Mar. 2020 ) + 15.005 (Jun. 2020 ) + 12.817 (Sep. 2020 ) = $25.02 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.
Co-Diagnostics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2020 is calculated as:
Earnings Yield (Joel Greenblatt) % (Q: Sep. 2020 ) | = | EBIT | / | Enterprise Value (Q: Sep. 2020 ) |
= | 25.022 | / | 374.95682 | |
= | 6.67 % |
Co-Diagnostics's Enterprise Value for the quarter that ended in Sep. 2020 was $374.96 Mil.
Co-Diagnostics's EBIT for the trailing twelve months (TTM) ended in Sep. 2020 was -1.735 (Dec. 2019 ) + -1.065 (Mar. 2020 ) + 15.005 (Jun. 2020 ) + 12.817 (Sep. 2020 ) = $25.02 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
No Headline